An open-label, randomized, single-dose, 2-sequence, 4-period, cross-over, phase 1 study to evaluate the safety and pharmacokinetics of CKD-331 in healthy adult volunteers
Phase 1 study to evaluate the safety and pharmacokinetics of CKD-331 in healthy adult volunteers